Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance

BACKGROUND: To evaluate the impact of concomitant use of probiotic BB-12 in metformin-treated patients with type 2 diabetes or prediabetes on glycemic control, metformin-related gastrointestinal side effects, and treatment compliance. METHODS: A total of 156 patients (mean [standard deviation] age:...

Descripción completa

Detalles Bibliográficos
Autores principales: Şahin, Kübra, Şahintürk, Yasin, Köker, Gökhan, Köker, Gülhan Özçelik, Bostan, Feyzi, Kök, Mehmet, Uyar, Seyit, Çekin, Ayhan Hilmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797791/
https://www.ncbi.nlm.nih.gov/pubmed/36098362
http://dx.doi.org/10.5152/tjg.2022.211063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797791/
https://www.ncbi.nlm.nih.gov/pubmed/36098362
http://dx.doi.org/10.5152/tjg.2022.211063

Ejemplares similares